Literature DB >> 26645640

Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?

Marco Genua1, Christoph Becker2, Stefania Vetrano3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26645640      PMCID： PMC4957480          DOI： 10.1093/ecco-jcc/jjv222

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  19 in total

1.  Everolimus for refractory Crohn's disease: a case report.

Authors:  Jérôme Dumortier; Marie-George Lapalus; Olivier Guillaud; Gilles Poncet; Marie-Claude Gagnieu; Christian Partensky; Jean-Yves Scoazec
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

2.  New mechanisms and targets for IBD Therapy: translational gastroenterology comes of age.

Authors:  Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Curr Drug Targets       Date:  2013-11       Impact factor: 3.465

Review 3.  IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

4.  A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.

Authors:  Walter Reinisch; Julian Panés; Marc Lémann; Stefan Schreiber; B Feagan; Steven Schmidt; Giacomo C Sturniolo; T Mikhailova; Olga Alexeeva; L Sanna; T Haas; S Korom; H Mayer
Journal:  Am J Gastroenterol       Date:  2008-07-30       Impact factor: 10.864

5.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production.

Authors:  Tatsuya Saitoh; Naonobu Fujita; Myoung Ho Jang; Satoshi Uematsu; Bo-Gie Yang; Takashi Satoh; Hiroko Omori; Takeshi Noda; Naoki Yamamoto; Masaaki Komatsu; Keiji Tanaka; Taro Kawai; Tohru Tsujimura; Osamu Takeuchi; Tamotsu Yoshimori; Shizuo Akira
Journal:  Nature       Date:  2008-10-05       Impact factor: 49.962

6.  Autophagy Contributes to the Induction of Anti-TNF Induced Macrophages.

Authors:  Alon D Levin; Pim J Koelink; Felicia M Bloemendaal; Anne Christine W Vos; Geert R D'Haens; Gijs R van den Brink; Manon E Wildenberg
Journal:  J Crohns Colitis       Date:  2015-09-27       Impact factor: 9.071

7.  Use of sirolimus (rapamycin) to treat refractory Crohn's disease.

Authors:  D C O Massey; F Bredin; M Parkes
Journal:  Gut       Date:  2008-09       Impact factor: 23.059

8.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.

Authors:  Jochen Hampe; Andre Franke; Philip Rosenstiel; Andreas Till; Markus Teuber; Klaus Huse; Mario Albrecht; Gabriele Mayr; Francisco M De La Vega; Jason Briggs; Simone Günther; Natalie J Prescott; Clive M Onnie; Robert Häsler; Bence Sipos; Ulrich R Fölsch; Thomas Lengauer; Matthias Platzer; Christopher G Mathew; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

Review 9.  Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal.

Authors:  Anita Annaházi; Tamás Molnár
Journal:  Gastroenterol Res Pract       Date:  2015-06-14       Impact factor: 2.260

10.  Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant.

Authors:  Petric Kuballa; Alan Huett; John D Rioux; Mark J Daly; Ramnik J Xavier
Journal:  PLoS One       Date:  2008-10-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.